UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

The journal of clinical endocrinology and metabolism, 2015-05, Vol.100 (5), p.1802-1810

2015

Volltextzugriff (PDF)

Genetic Syndromes of Severe Insulin Resistance

Endocrine reviews, 2011-08, Vol.32 (4), p.498-514

2011

Volltextzugriff (PDF)

The liver diseases of lipodystrophy: The long-term effect of leptin treatment

Journal of hepatology, 2013-07, Vol.59 (1), p.131-137

2013

Volltextzugriff (PDF)

Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis

The Journal of clinical investigation, 2009-02, Vol.119 (2), p.315-322

2009

Volltextzugriff (PDF)

Autoimmune forms of hypoglycemia

Medicine (Baltimore), 2009-05, Vol.88 (3), p.141-153

2009

Volltextzugriff (PDF)

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Clinical endocrinology (Oxford), 2016-07, Vol.85 (1), p.137-149

2016

Volltextzugriff (PDF)

Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease

Proceedings of the National Academy of Sciences - PNAS, 2014-06, Vol.111 (24), p.8901-8906

2014

Volltextzugriff (PDF)

Effects of metreleptin on proteinuria in patients with lipodystrophy

The journal of clinical endocrinology and metabolism, 2019-09, Vol.104 (9), p.4169-4177

2019

Volltextzugriff (PDF)

Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy

Diabetes (New York, N.Y.), 2005-07, Vol.54 (7), p.1994-2002

2005

Volltextzugriff (PDF)

Lipid Regulation in Lipodystrophy Versus the Obesity-Associated Metabolic Syndrome: The Dissociation of HDL-C and Triglycerides

The journal of clinical endocrinology and metabolism, 2014-09, Vol.99 (9), p.E1676-E1680

2014

Volltextzugriff (PDF)

A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation

The journal of clinical endocrinology and metabolism, 2018-03, Vol.103 (3), p.1005-1014

2018

Volltextzugriff (PDF)

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy

Hepatology (Baltimore, Md.), 2005-04, Vol.41 (4), p.753-760

2005

Volltextzugriff (PDF)

Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy

Journal of clinical lipidology, 2017-03, Vol.11 (2), p.543-550

2017

Volltextzugriff (PDF)

Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy

Diabetes care, 2014-04, Vol.37 (4), p.1101-1107

2014

Volltextzugriff (PDF)

Paradoxical Elevation of High–Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor Antibodies

Diabetes (New York, N.Y.), 2007-06, Vol.56 (6), p.1712-1717

2007

Volltextzugriff (PDF)

Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction : Clinical utility in severe insulin resistance

Diabetes care, 2008-05, Vol.31 (5), p.977-979

2008

Volltextzugriff (PDF)

Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy

Metabolism, clinical and experimental, 2007-04, Vol.56 (4), p.508-516

2007

Volltextzugriff (PDF)

Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin Therapy

The journal of clinical endocrinology and metabolism, 2008-01, Vol.93 (1), p.26-31

2008

Volltextzugriff (PDF)

The global burden of lipodystrophy, a rare disease

Annals of global health, 2016-08, Vol.82 (3), p.591-591

2016

Volltextzugriff (PDF)

Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity

Medicine (Baltimore), 2008-03, Vol.87 (2), p.70-86

2008

Volltextzugriff (PDF)

High-dose insulin therapy: is it time for U-500 insulin?

Endocrine practice, 2009-01, Vol.15 (1), p.71-79

2009

Volltextzugriff (PDF)

Complement Abnormalities in Acquired Lipodystrophy Revisited

The journal of clinical endocrinology and metabolism, 2009-01, Vol.94 (1), p.10-16

2009

Volltextzugriff (PDF)

Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction

Diabetes care, 2008-05, Vol.31 (5), p.977-979

2008

Volltextzugriff (PDF)

Efficacy of Recombinant Methionyl Human Leptin Therapy for the Extreme Insulin Resistance of the Rabson-Mendenhall Syndrome

The journal of clinical endocrinology and metabolism, 2004-04, Vol.89 (4), p.1548-1554

2004

Volltextzugriff (PDF)

The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients

Metabolism, clinical and experimental, 2005-02, Vol.54 (2), p.255-263

2005

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

Genetic Syndromes of Severe Insulin Resistance

The liver diseases of lipodystrophy: The long-term effect of leptin treatment

Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis

Autoimmune forms of hypoglycemia

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease

Effects of metreleptin on proteinuria in patients with lipodystrophy

Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy

Lipid Regulation in Lipodystrophy Versus the Obesity-Associated Metabolic Syndrome: The Dissociation of HDL-C and Triglycerides

A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy

Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy

Effects of Leptin Replacement Therapy on Pancreatic β-Cell Function in Patients With Lipodystrophy

Paradoxical Elevation of High–Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor Antibodies

Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction : Clinical utility in severe insulin resistance

Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy

Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin Therapy

The global burden of lipodystrophy, a rare disease

Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity

High-dose insulin therapy: is it time for U-500 insulin?

Complement Abnormalities in Acquired Lipodystrophy Revisited

Plasma Adiponectin as a Marker of Insulin Receptor Dysfunction

Efficacy of Recombinant Methionyl Human Leptin Therapy for the Extreme Insulin Resistance of the Rabson-Mendenhall Syndrome

The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients

Suchergebnisse filtern